Foreign investors boost stake as Viyash Scientific scales up its pharmaceutical platform

Foreign institutional investors are increasing their holdings in Viyash Scientific amid signs of a strategic shift towards a broader pharmaceutical platform, fuelled by robust earnings growth and a focus on animal and human health segments. Foreign institutional investors have been…













